Data

Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump

A three-year, investigator-led, prospective study of Japanese patients who received an Impella® heart pump finds use of Impella...
July 29, 2020
Education

Impella Groin Management

Best Practices for Patients Supported with Impella® (Part 5) In this video, Dr. Behnam Tehrani discus...
July 30, 2020
Cardiogenic Shock

Mechanical Circulatory Support in AMI Cardiogenic Shock

Insights on MCS Use and Timing from Dr. Jacob Møller in Denmark Jacob Møller MD, PhD, an intensivist...
July 27, 2020
Digital Resources

Resource Library
Digital Resources

Practice Essentials
Online Education

Abiomed Academy

Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events

08.05.20
Topics in Surgery: Acute Decompensated Heart Failure
Details
08.12.20
HRPCI and Complete Revascularization
Details
08.26.20
5.0/5.5 Experience, Escalation of Care, and Building a Surgical Program
Details
09.16.20
Transitioning Patients in Cardiogenic Shock to Heart Recovery or VAD/Transplant
Details

Dr. Jeff Popma Discusses PROTECT III
data with Dr. Seth Bilazarian

#ProtectedPCI

New clinical data from Japan shows 77% survival rate at 30 days in AMI cardiogenic shock patients. Watch the video to hear Dr. Yoshiki Sawa and Abiomed's new Chief Medical Officer, @DrChuckSimonton, discuss the details of the study here: bit.ly/39KvKCJ #cardiotwitter pic.twitter.com/d9OF1VQRqM

From Protected PCI's Twitter

prev · next
#AbiomedImpella

MVPvets has appointed a new board member and launched The Academy, providing veterans with virtual training and mentorship. MVPvets is a non-profit founded by Abiomed’s CEO @MikeMinogueABMD. Learn more here: prn.to/33qF0en pic.twitter.com/2jJdYH5Omv

From Abiomed's Twitter

prev · next